Arkolith/Insider Trading/KALA/Form 4

Lazar David E.

Chief Executive Officer, DirectorKALA BIO, Inc. (KALA) · full profile →Form 4 · filed Nov 26, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
0 non-derivative · 1 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 24, 2025Grant(A)900K——900K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000921895-25-003208) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML